The North American Income Trust plc publishes presentation on portfolio performance and investment strategy
Reuters
Nov 25
The <a href="https://laohu8.com/S/FNCSF">North American</a> Income Trust plc publishes presentation on portfolio performance and investment strategy
The North American Income Trust plc has published a presentation outlining its recent portfolio performance and key holdings. As of 31 October 2025, the Trust reported a net asset value $(NAV)$ total return of 17.8% over the past year, compared to a 15.1% return from its reference index, the Russell 1000® Value Index (in sterling terms). The Trust's portfolio remains primarily focused on US equities, with 94.9% allocated to the United States and 5.1% to Canada. The top sector exposures include financials (21.8%) and health care (18.3%), while notable holdings feature Chevron, CVS Health, Philip Morris International, and Johnson & Johnson. The Trust reported a yield of 3.5% and a share price of 357.0p, representing an 8% discount to its NAV. You can access the full presentation through the link below.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The North American Income Trust plc published the original content used to generate this news brief on November 25, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.